Gut-brain chemokine changes in portal hypertensive rats |
| |
Authors: | Merino Joaquin Aller Maria-Angeles Rubio Sandra Arias Natalia Nava Maria-Paz Loscertales Maria Arias Jaime Arias Jorge-Luis |
| |
Affiliation: | 1. Department of Surgery I, School of Medicine, Complutense University of Madrid, Plaza de Ram??n y Cajal s.n, 28040, Madrid, Spain 3. Department of Psychobiology, School of Psychology, Autonomous University of Madrid, 28049, Cantoblanco, Madrid, Spain 4. Neurosciences Laboratory, School of Psychology, University of Oviedo, Pza. de Feijoo s/n, 33003, Oviedo, Asturias, Spain 5. Department of Physiology (Animal Physiology II), School of Biology, Complutense University of Madrid, J. A. Novais 2, 28040, Madrid, Spain 6. Department of Surgery, Massachusetts General Hospital, 1055 Fruit St., Boston, MA, 02114, USA
|
| |
Abstract: | Background Hepatic encephalopathy is a syndrome whose physiopathology is poorly understood; therefore, current diagnostic tests are imperfect and modern therapy is nonspecific. Particularly, it has been suggested that inflammation plays an important role in the pathogenesis of portal hypertensive encephalopathy in the rat. Aim We have studied an experimental model of portal hypertension based on a triple partial portal vein ligation in the rat to verify this hypothesis. Methods One month after portal hypertension we assayed in the splanchnic area (liver, small bowel and mesenteric lymph nodes) and in the central nervous system (hippocampus and cerebellum) fractalkine (CX3CL1) and stromal cell-derived factor alpha (SDF1-??) as well as their respective receptors (CX3CR1 and CXCR4) because of their key role in inflammatory processes. Results The significant increase of fractalkine in mesenteric lymph nodes (P?0.05) and its receptor (CX3CR1) in the small bowel (P?0.05) and hippocampus (P?0.01), associated with the increased expression of SDF1-?? in the hippocampus (P?0.01) and the cerebellum (P?0.01) suggest that prehepatic portal hypertension in the rat induces important alterations in the expression of chemokines in the gut-brain axis. Conclusion The present study revealed that portal hypertension is associated with splanchnic-brain inflammatory alterations mediated by chemokines. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|